TG Therapeutics reported $92K in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US USD 92K 479K
Amgen AMGN:US USD 5.09B 28M
Bayer BAYN:GR EUR 7.03B 105M
Biogen BIIB:US USD 2.04B 66.1M
Corcept Therapeutics CORT:US USD 100.39M 1.68M
Gilead Sciences GILD:US USD 5.99B 346M
Infinity Pharmaceuticals INFI:US USD 283K 11K
Intercept Pharmaceuticals ICPT:US USD 77.16M 5.72M
Johnson & Johnson JNJ:US USD 15.94B 56M
Karyopharm Therapeutics KPTI:US USD 35.16M 3.58M
Novartis NOVN:VX USD 9.18B 151M
Ptc Therapeutics PTCT:US USD 203.12M 47.23M
Regeneron Pharmaceuticals REGN:US USD 2.62B 58.3M
Roche Holding ROG:VX 22.73B 924M
Vertex Pharmaceuticals VRTX:US USD 2.04B 110.5M